B-myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 8, 2014, Pages 3122-3127

  Baker, Stacey J ^a   Ma'ayan, Avi ^a   Lieu, Yen K ^a,c   John, Premila ^b   Reddy, M V Ramana ^a   Chen, Edward Y ^a   Duan, Qiaonan ^a   Snoeck, Hans Willem ^a,c   Reddy, E Premkumar ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

Myelodisplastic syndrome; Myeloipiesis

Indexed keywords

B MYB PROTEIN; CYCLIN D1; PROTEIN MYB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL COMPARTMENTALIZATION; CELL COUNT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL PROLIFERATION; CELL TYPE; COLONY FORMING UNIT; COLONY FORMING UNIT M; CONTROLLED STUDY; ERYTHROID CELL; GENE EXPRESSION; GENE INACTIVATION; GRANULOCYTE PRECURSOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LYMPHOCYTE; LYMPHOID CELL; MOUSE; MYELOID PROGENITOR CELL; NEUTROPHIL; NONHUMAN; ONCOGENE C MYB; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE; THYMOCYTE;

MYELODISPLASTIC SYNDROME; MYELOIPIESIS;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CROSSES, GENETIC; DNA PRIMERS; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MYELOID PROGENITOR CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 84896879034     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315464111     Document Type: Article

References (54)

1. Iwasaki H, Akashi K (2007) Myeloid lineage commitment from the hematopoietic stem cell. Immunity 26(6):726-740. (Pubitemid 46907674)
2. Seita J, Weissman IL (2010) Hematopoietic stem cell: Self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med 2(6):640- 653.
3. Adolfsson J, et al. (2005) Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121(2):295- 306.
4. Mucenski ML, et al. (1991) A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65(4):677-689.
5. Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K (2004) Critical functions for c-Myb at three checkpoints during thymocyte development. Nat Immunol 5(7):721-729. (Pubitemid 39023304)
6. Lieu YK, Kumar A, Pajerowski AG, Rogers TJ, Reddy EP (2004) Requirement of c-myb in T cell development and in mature T cell function. Proc Natl Acad Sci USA 101(41):14853-14858. (Pubitemid 39410764)
7. Fahl SP, Crittenden RB, Allman D, Bender TP (2009) c-Myb is required for pro-B cell differentiation. J Immunol 183(9):5582-5592.
8. Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP (2005) c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 23(3):275-286. (Pubitemid 41317795)
9. Vegiopoulos A, García P, Emambokus N, Frampton J (2006) Coordination of erythropoiesis by the transcription factor c-Myb. Blood 107(12):4703-4710. (Pubitemid 43882618)
10. García P, et al. (2009) Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis. EMBO J 28(10):1492-1504.
11. Lieu YK, Reddy EP (2009) Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci USA 106(51):21689-21694.
12. Lieu YK, Reddy EP (2012) Impaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout mice. Cell Cycle 11(18):3504-3512.
13. Tanaka Y, Patestos NP, Maekawa T, Ishii S (1999) B-myb is required for inner cell mass formation at an early stage of development. J Biol Chem 274(40):28067-28070.
14. Kühn R, Schwenk F, Aguet M, Rajewsky K (1995) Inducible gene targeting in mice. Science 269(5229):1427-1429.
15. Kiel MJ, et al. (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121(7):1109-1121. (Pubitemid 40884400)
16. Akashi K, Traver D, Miyamoto T, Weissman IL (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404(6774):193-197. (Pubitemid 30154488)
17. Kondo M, Weissman IL, Akashi K (1997) Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91(5):661-672. (Pubitemid 27513657)
18. Passegué E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL (2005) Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 202(11):1599-1611. (Pubitemid 41746605)
19. García P, Frampton J (2006) The transcription factor B-Myb is essential for S-phase progression and genomic stability in diploid and polyploid megakaryocytes. J Cell Sci 119(Pt 8):1483-1493. (Pubitemid 43732977)
20. Tarasov KV, et al. (2008) B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells. PLoS ONE 3(6):e2478.
21. Knight AS, Notaridou M, Watson RJ (2009) A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells. Oncogene 28(15):1737-1747.
22. Lorvellec M, et al. (2010) B-Myb is critical for proper DNA duplication during an unperturbed S phase in mouse embryonic stem cells. Stem Cells 28(10):1751-1759.
23. Down CF, Millour J, Lam EW, Watson RJ (2012) Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb. Biochim Biophys Acta 1819(8):855-862.
24. Sadasivam S, Duan S, DeCaprio JA (2012) The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev 26(5):474-489.
25. Zhan M, et al. (2012) The B-MYB transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells. PLoS ONE 7(8):e42350.
26. Chen EY, et al. (2013) Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14:128.
27. Lachmann A, et al. (2010) ChEA: Transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26(19):2438-2444.
28. Liu X, et al. (2008) Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells. Cell Res 18(12):1177-1189.
29. Kim J, Chu J, Shen X, Wang J, Orkin SH (2008) An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132(6):1049-1061. (Pubitemid 351381745)
30. Zhao L, et al. (2011) Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb. Nucleic Acids Res 39(11):4664-4679.
31. Peng JC, et al. (2009) Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139(7):1290-1302.
32. Chen X, et al. (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133(6):1106-1117. (Pubitemid 351787745)
33. Kassouf MT, et al. (2010) Genome-wide identification of TAL1's functional targets: Insights into its mechanisms of action in primary erythroid cells. Genome Res 20(8):1064-1083.
34. Wilson NK, et al. (2010) Combinatorial transcriptional control in blood stem/progenitor cells: Genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7(4):532-544.
35. DeGregori J, Kowalik T, Nevins JR (1995) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 15(8):4215-4224.
36. Liu N, Lucibello FC, Zwicker J, Engeland K, Müller R (1996) Cell cycle-regulated repression of B-myb transcription: Cooperation of an E2F site with a contiguous corepressor element. Nucleic Acids Res 24(15):2905-2910. (Pubitemid 26257156)
37. Lam EW, Watson RJ (1993) An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12(7):2705-2713. (Pubitemid 23218320)
38. Joaquin M, Watson RJ (2003) Cell cycle regulation by the B-Myb transcription factor. Cell Mol Life Sci 60(11):2389-2401. (Pubitemid 37487259)
39. Tsuzuki S, Seto M (2013) TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice. Stem Cells 31(2):236-247.
40. Golay J, et al. (1997) Redundant functions of B-Myb and c-Myb in differentiating myeloid cells. Cell Growth Differ 8(12):1305-1316. (Pubitemid 28008727)
41. Watson RJ, Robinson C, Lam EW (1993) Transcription regulation by murine B-myb is distinct from that by c-myb. Nucleic Acids Res 21(2):267-272. (Pubitemid 23151897)
42. Rosenbauer F, Tenen DG (2007) Transcription factors in myeloid development: Balancing differentiation with transformation. Nat Rev Immunol 7(2):105-117. (Pubitemid 46174858)
43. Cochrane SW, Zhao Y, Welner RS, Sun XH (2009) Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions. Blood 113(5):1016-1026.
44. Zhang P, et al. (2004) Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 21(6):853-863. (Pubitemid 39642186)
45. Pietras EM, Warr MR, Passegué E (2011) Cell cycle regulation in hematopoietic stem cells. J Cell Biol 195(5):709-720.
46. Heinrichs S, et al. (2013) MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy. Elife 2:e00825.
47. García P, Berlanga O, Watson R, Frampton J (2005) Generation of a conditional allele of the B-myb gene. Genesis 43(4):189-195. (Pubitemid 43117835)
48. Shepard JL, et al. (2005) A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci USA 102(37):13194-13199. (Pubitemid 41325000)
49. Stern HM, et al. (2005) Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol 1(7):366-370.
50. Casimiro MC, Crosariol M, Loro E, Li Z, Pestell RG (2012) Cyclins and cell cycle control in cancer and disease. Genes Cancer 3(11-12):649-657.
51. Zimmermann M, et al. (2012) Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin. J Biol Chem 287(27):22838-22853.
52. Will B, et al. (2012) Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. Blood 120(10):2076-2086.
53. Pang WW, et al. (2013) Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc Natl Acad Sci USA 110(8):3011-3016.
54. Clarke M, et al. (2013) MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia. Leukemia 27(3):661-670.